Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Laurus Labs (LAURUS IN)
Watchlist
37
Analysis
Health Care
•
India
Laurus Labs Limited researches, develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India and internationally. It offers APIs for anti-retroviral and hepatitis C; and APIs in oncology and other therapeutic areas. .
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
29 Jun 2024 19:06
Laurus Labs Ltd - 540222 - Disclosure Under Regulation 30 Of SEBI LODR
Attachment
Exchange Announcement •
28 Jun 2024 23:25
Laurus Labs Ltd - 540222 - Closure of Trading Window
Attachment
Exchange Announcement •
21 Jun 2024 18:44
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Credit Rating
Attachment
Exchange Announcement •
19 Jun 2024 18:06
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Attachment
Exchange Announcement •
18 Jun 2024 21:58
Laurus Labs Ltd - 540222 - Business Responsibility and Sustainability Reporting (BRSR)
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.1
x